Rakovina Therapeutics Inc. (TSXV:RKV)
Canada · Delayed Price · Currency is CAD 0.2200
+0.0100 (4.76%)
At close: Aug 28, 2026
Rakovina Therapeutics Market Cap
Rakovina Therapeutics has a market cap or net worth of CAD 5.37 million as of August 28, 2026. Its market cap has decreased by -49.21% in one year.
Market Cap
5.37M
Enterprise Value
7.79M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.22
ChartMarket Cap Chart
Since April 1, 2021, Rakovina Therapeutics's market cap has decreased from 14.88M to 5.37M, a decrease of -63.89%. That is a compound annual growth rate of -17.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 5.37M | 153.97% |
| Dec 31, 2025 | 2.11M | -92.08% |
| Dec 31, 2024 | 26.69M | 348.09% |
| Dec 29, 2023 | 5.96M | -52.61% |
| Dec 29, 2022 | 12.57M | -18.16% |
| Dec 31, 2021 | 15.36M | 3.25% |
| Apr 1, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Glow Lifetech | 8.66M |
| XORTX Therapeutics | 5.54M |
| PharmaTher Holdings | 5.46M |
| MYND Life Sciences | 5.22M |
| Kane Biotech | 5.13M |
| Innovotech | 4.63M |
| Grey Matters Health | 4.46M |
| Restart Life Sciences | 4.36M |